Skip to content

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH

Interest of a Systematic Assessment of the Treatment of Lower Urinary Tract Symptoms (LUTS) in the Management of Benign Prostatic Hyperplasia (BPH) in Urology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03179670
Acronym
UROEVAL
Enrollment
625
Registered
2017-06-07
Start date
2017-06-15
Completion date
2018-06-30
Last updated
2019-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Brief summary

The high level of unsatisfactory outcome observed in patients treated for LUTS associated with BPH with respect to the different existing therapeutic options strongly emphasizes the need for treatment optimisation in daily practice by a careful LUTS monitoring and treatment adjustment when needed. The poorer outcome observed in patients for whom treatment has been initiated recently suggests that the duration of the disease itself may influence the patient satisfaction.To achieve this goal, we propose to systematically assess LUTS associated with BPH in patients treated for at least 6 months and to assess whether an alpha-blocker therapy initiation/modification may improve the outcome in case of persisting symptoms. We also investigate the influence of the symptom duration on the frequency of unsatisfactory outcome.

Interventions

None listed

Sponsors

ClinSearch
CollaboratorOTHER
RECORDATI GROUP
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients aged 60 years or more suffering from LUTS/BPH AND medically treated for at least 6 months.

Exclusion criteria

* Patients with prostate cancer * Patients requiring surgical treatment * The absence of Lower Urinary Tract Symptoms * Treatment initiation for less than 6 months * Cognitive disorders or other pathologies leading to the inability to give its consent to the collection of data. * Refusal to participate.

Design outcomes

Primary

MeasureTime frame
Percentage of patients treated for LUTS associated with BPH displaying unsatisfactory outcome after at least 6 months of treatment and not requiring surgical treatment.6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026